# Appian Corp: financial statements, quarterly

APPN · Nasdaq · CIK 1441683 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/appn.md) · [Financials](/companies/appn/financials.md) · [Filings](/companies/appn/filings.md) · [Insiders](/companies/appn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/appn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137](/filings/0001441683-24-000097.md) | [145 d](/filings/0001441683-26-000013.md) | [150](/filings/0001441683-25-000041.md) | [146](/filings/0001441683-25-000053.md) | [154](/filings/0001441683-25-000068.md) | [167 d](/filings/0001441683-26-000013.md) | [166](/filings/0001441683-26-000032.md) | [171](/filings/0001441683-26-000053.md) | [187](/filings/0001441683-25-000068.md) | [203 d](/filings/0001441683-26-000013.md) | [202](/filings/0001441683-26-000032.md) | [203](/filings/0001441683-26-000053.md) |
| Cost of revenue | $m | [36.1](/filings/0001441683-24-000097.md) | [51.3 d](/filings/0001441683-26-000013.md) | [38.0](/filings/0001441683-25-000041.md) | [39.4](/filings/0001441683-25-000053.md) | [37.1](/filings/0001441683-25-000068.md) | [53.7 d](/filings/0001441683-26-000013.md) | [44.0](/filings/0001441683-26-000032.md) | [49.0](/filings/0001441683-26-000053.md) | [45.3](/filings/0001441683-25-000068.md) | [71.5 d](/filings/0001441683-26-000013.md) | [54.4](/filings/0001441683-26-000032.md) | [58.5](/filings/0001441683-26-000053.md) |
| Gross profit | $m | [101](/filings/0001441683-24-000097.md) | [94.0 d](/filings/0001441683-26-000013.md) | [112](/filings/0001441683-25-000041.md) | [107](/filings/0001441683-25-000053.md) | [117](/filings/0001441683-25-000068.md) | [113 d](/filings/0001441683-26-000013.md) | [122](/filings/0001441683-26-000032.md) | [122](/filings/0001441683-26-000053.md) | [142](/filings/0001441683-25-000068.md) | [131 d](/filings/0001441683-26-000013.md) | [148](/filings/0001441683-26-000032.md) | [145](/filings/0001441683-26-000053.md) |
| Research and development | $m | [37.1](/filings/0001441683-24-000097.md) | [41.9 d](/filings/0001441683-26-000013.md) | [39.8](/filings/0001441683-25-000041.md) | [39.4](/filings/0001441683-25-000053.md) | [38.6](/filings/0001441683-25-000068.md) | [45.6 d](/filings/0001441683-26-000013.md) | [41.8](/filings/0001441683-26-000032.md) | [42.7](/filings/0001441683-26-000053.md) | [40.3](/filings/0001441683-25-000068.md) | [52.1 d](/filings/0001441683-26-000013.md) | [46.3](/filings/0001441683-26-000032.md) | [47.3](/filings/0001441683-26-000053.md) |
| Operating income | $m | [(15.2)](/filings/0001441683-24-000097.md) | [(16.8) d](/filings/0001441683-26-000013.md) | [(19.5)](/filings/0001441683-25-000041.md) | [(39.2)](/filings/0001441683-25-000053.md) | [(7.2)](/filings/0001441683-25-000068.md) | [5.0 d](/filings/0001441683-26-000013.md) | [(0.8)](/filings/0001441683-26-000032.md) | [(11.0)](/filings/0001441683-26-000053.md) | [13.1](/filings/0001441683-25-000068.md) | [(0.7) d](/filings/0001441683-26-000013.md) | [3.2](/filings/0001441683-26-000032.md) | [(5.4)](/filings/0001441683-26-000053.md) |
| Interest expense | $m | [4.9](/filings/0001441683-24-000097.md) | [5.1 d](/filings/0001441683-26-000013.md) | [5.6](/filings/0001441683-25-000041.md) | [6.1](/filings/0001441683-25-000053.md) | [6.2](/filings/0001441683-25-000068.md) | [5.7 d](/filings/0001441683-26-000013.md) | [5.3](/filings/0001441683-26-000032.md) | [5.3](/filings/0001441683-26-000053.md) | [5.3](/filings/0001441683-25-000068.md) | [4.9 d](/filings/0001441683-26-000013.md) | [4.2](/filings/0001441683-26-000032.md) | [3.8](/filings/0001441683-26-000053.md) |
| Income tax | $m | [0.2](/filings/0001441683-24-000097.md) | [1.1 d](/filings/0001441683-26-000013.md) | [(0.5)](/filings/0001441683-25-000041.md) | [(0.2)](/filings/0001441683-25-000053.md) | [1.3](/filings/0001441683-25-000068.md) | [0.4 d](/filings/0001441683-26-000013.md) | [0.7](/filings/0001441683-26-000032.md) | [1.6](/filings/0001441683-26-000053.md) | [1.4](/filings/0001441683-25-000068.md) | [1.5 d](/filings/0001441683-26-000013.md) | [0.6](/filings/0001441683-26-000032.md) | [1.8](/filings/0001441683-26-000053.md) |
| Net income | $m | [(22.3)](/filings/0001441683-24-000097.md) | [(10.0) d](/filings/0001441683-26-000013.md) | [(32.9)](/filings/0001441683-25-000068.md) | [(43.6)](/filings/0001441683-25-000068.md) | [(2.1)](/filings/0001441683-25-000068.md) | [(13.6) d](/filings/0001441683-26-000013.md) | [(1.2)](/filings/0001441683-26-000053.md) | [(0.3)](/filings/0001441683-26-000053.md) | [7.8](/filings/0001441683-25-000068.md) | [(5.1) d](/filings/0001441683-26-000013.md) | [(1.5)](/filings/0001441683-26-000053.md) | [(11.8)](/filings/0001441683-26-000053.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001441683-24-000097.md) | not reported | [(0.45)](/filings/0001441683-25-000041.md) | [(0.60)](/filings/0001441683-25-000053.md) | [(0.03)](/filings/0001441683-25-000068.md) | not reported | [(0.02)](/filings/0001441683-26-000032.md) | [0.00](/filings/0001441683-26-000053.md) | [0.10](/filings/0001441683-25-000068.md) | not reported | [(0.02)](/filings/0001441683-26-000032.md) | [(0.16)](/filings/0001441683-26-000053.md) |
| Basic EPS | $ per share | [(0.30)](/filings/0001441683-24-000097.md) | not reported | [(0.45)](/filings/0001441683-25-000041.md) | [(0.60)](/filings/0001441683-25-000053.md) | [(0.03)](/filings/0001441683-25-000068.md) | not reported | [(0.02)](/filings/0001441683-26-000032.md) | [0.00](/filings/0001441683-26-000053.md) | [0.11](/filings/0001441683-25-000068.md) | not reported | [(0.02)](/filings/0001441683-26-000032.md) | [(0.16)](/filings/0001441683-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [131](/filings/0001441683-24-000097.md) | [149](/filings/0001441683-25-000017.md) | [170](/filings/0001441683-24-000042.md) | [121](/filings/0001441683-24-000070.md) | [99.2](/filings/0001441683-24-000097.md) | [119](/filings/0001441683-26-000013.md) | [135](/filings/0001441683-25-000041.md) | [112](/filings/0001441683-25-000053.md) | [125](/filings/0001441683-25-000068.md) | [136](/filings/0001441683-26-000053.md) | [150](/filings/0001441683-26-000032.md) | [121](/filings/0001441683-26-000053.md) |
| Current assets | $m | [385](/filings/0001441683-23-000093.md) | [414](/filings/0001441683-25-000017.md) | [390](/filings/0001441683-24-000042.md) | [364](/filings/0001441683-24-000070.md) | [360](/filings/0001441683-24-000097.md) | [436](/filings/0001441683-26-000013.md) | [412](/filings/0001441683-25-000041.md) | [412](/filings/0001441683-25-000053.md) | [439](/filings/0001441683-25-000068.md) | [519](/filings/0001441683-26-000053.md) | [454](/filings/0001441683-26-000032.md) | [410](/filings/0001441683-26-000053.md) |
| Total assets | $m | [597](/filings/0001441683-23-000093.md) | [628](/filings/0001441683-25-000017.md) | [595](/filings/0001441683-24-000042.md) | [555](/filings/0001441683-24-000070.md) | [550](/filings/0001441683-24-000097.md) | [621](/filings/0001441683-26-000013.md) | [593](/filings/0001441683-25-000041.md) | [591](/filings/0001441683-25-000053.md) | [612](/filings/0001441683-25-000068.md) | [691](/filings/0001441683-26-000053.md) | [623](/filings/0001441683-26-000032.md) | [586](/filings/0001441683-26-000053.md) |
| Current liabilities | $m | [323](/filings/0001441683-23-000093.md) | [371](/filings/0001441683-25-000017.md) | [294](/filings/0001441683-24-000042.md) | [294](/filings/0001441683-24-000070.md) | [298](/filings/0001441683-24-000097.md) | [355](/filings/0001441683-26-000013.md) | [330](/filings/0001441683-25-000041.md) | [347](/filings/0001441683-25-000053.md) | [370](/filings/0001441683-25-000068.md) | [452](/filings/0001441683-26-000053.md) | [403](/filings/0001441683-26-000032.md) | [412](/filings/0001441683-26-000053.md) |
| Total liabilities | $m | [529](/filings/0001441683-23-000093.md) | [575](/filings/0001441683-25-000017.md) | [605](/filings/0001441683-24-000042.md) | [600](/filings/0001441683-24-000070.md) | [600](/filings/0001441683-24-000097.md) | [654](/filings/0001441683-26-000013.md) | [625](/filings/0001441683-25-000041.md) | [644](/filings/0001441683-25-000053.md) | [660](/filings/0001441683-25-000068.md) | [738](/filings/0001441683-26-000053.md) | [682](/filings/0001441683-26-000032.md) | [691](/filings/0001441683-26-000053.md) |
| Long-term debt | $m | [142](/filings/0001441683-23-000093.md) | [140](/filings/0001441683-25-000017.md) | [248](/filings/0001441683-24-000042.md) | [246](/filings/0001441683-24-000070.md) | [243](/filings/0001441683-24-000097.md) | [241](/filings/0001441683-26-000013.md) | [238](/filings/0001441683-25-000041.md) | [236](/filings/0001441683-25-000053.md) | [234](/filings/0001441683-25-000068.md) | [231](/filings/0001441683-26-000053.md) | [229](/filings/0001441683-26-000032.md) | [226](/filings/0001441683-26-000053.md) |
| Current portion of debt | $m | [65.4](/filings/0001441683-23-000093.md) | [66.4](/filings/0001441683-25-000017.md) | [7.1](/filings/0001441683-24-000042.md) | [8.3](/filings/0001441683-24-000070.md) | [9.6](/filings/0001441683-24-000097.md) | [9.6](/filings/0001441683-26-000013.md) | [9.6](/filings/0001441683-25-000041.md) | [9.6](/filings/0001441683-25-000053.md) | [12.1](/filings/0001441683-25-000068.md) | [9.6](/filings/0001441683-26-000053.md) | [9.6](/filings/0001441683-26-000032.md) | [9.6](/filings/0001441683-26-000053.md) |
| Shareholders' equity | $m | [68.1](/filings/0001441683-24-000097.md) | [52.3](/filings/0001441683-26-000013.md) | [(9.7)](/filings/0001441683-25-000068.md) | [(45.7)](/filings/0001441683-25-000068.md) | [(49.8)](/filings/0001441683-25-000068.md) | [(32.6)](/filings/0001441683-26-000053.md) | [(31.7)](/filings/0001441683-26-000053.md) | [(53.7)](/filings/0001441683-26-000053.md) | [(48.5)](/filings/0001441683-25-000068.md) | [(47.0)](/filings/0001441683-26-000053.md) | [(59.0)](/filings/0001441683-26-000053.md) | [(105)](/filings/0001441683-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(65.0) d](/filings/0001441683-24-000097.md) | [(8.2) d](/filings/0001441683-26-000013.md) | [18.9](/filings/0001441683-25-000041.md) | [(17.6) d](/filings/0001441683-25-000053.md) | [(8.2) d](/filings/0001441683-25-000068.md) | [13.9 d](/filings/0001441683-26-000013.md) | [45.0](/filings/0001441683-26-000032.md) | [(1.9) d](/filings/0001441683-26-000053.md) | [18.7 d](/filings/0001441683-25-000068.md) | [1.1 d](/filings/0001441683-26-000013.md) | [48.8](/filings/0001441683-26-000032.md) | [12.1 d](/filings/0001441683-26-000053.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001441683-24-000097.md) | [1.4 d](/filings/0001441683-26-000013.md) | [2.2](/filings/0001441683-25-000041.md) | [0.7 d](/filings/0001441683-25-000053.md) | [0.4 d](/filings/0001441683-25-000068.md) | [0.5 d](/filings/0001441683-26-000013.md) | [0.7](/filings/0001441683-26-000032.md) | [1.1 d](/filings/0001441683-26-000053.md) | [0.7 d](/filings/0001441683-25-000068.md) | [0.9 d](/filings/0001441683-26-000013.md) | [0.2](/filings/0001441683-26-000032.md) | [2.3 d](/filings/0001441683-26-000053.md) |
| Share repurchases | $m | [0.0 d](/filings/0001441683-24-000097.md) | [0.0 d](/filings/0001441683-26-000013.md) | [50.0](/filings/0001441683-25-000041.md) | [0.0 d](/filings/0001441683-25-000053.md) | [0.0 d](/filings/0001441683-25-000068.md) | [0.0 d](/filings/0001441683-26-000013.md) | [0.0](/filings/0001441683-26-000032.md) | [10.0 d](/filings/0001441683-26-000053.md) | [10.0 d](/filings/0001441683-25-000068.md) | [0.0 d](/filings/0001441683-26-000013.md) | [21.8](/filings/0001441683-26-000032.md) | [43.9 d](/filings/0001441683-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.5](/filings/0001441683-23-000093.md) | [72.9](/filings/0001441683-24-000042.md) | [73.0](/filings/0001441683-24-000070.md) | [73.2](/filings/0001441683-24-000097.md) | [73.3](/filings/0001441683-25-000041.md) | [72.3](/filings/0001441683-25-000053.md) | [72.4](/filings/0001441683-25-000068.md) | [74.1](/filings/0001441683-26-000032.md) | [74.2](/filings/0001441683-26-000053.md) | [74.6](/filings/0001441683-25-000068.md) | [73.8](/filings/0001441683-26-000032.md) | [72.9](/filings/0001441683-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.